Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McMaster University

$135,000.00

Reprogrammed pyrimidine metabolism in MYC-amplified medulloblastoma.

EF 2022-23

Résumé
Brain tumors represent the leading cause of childhood cancer mortality, due to their highly aggressive and often incurable nature. Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Whereas the fine-tuning of multimodal therapies have significantly improved the survivorship of MB, there are still fundamental gaps in our molecular understanding of MB recurrence, which remains a terminal diagnosis. Our preliminary findings have shown that MB tumor cells have altered cellular metabolism in comparison to normal developing nervous tissues. The goal of our proposed work is to understand how alterations in cellular metabolism allow recurrent MB tumor cells to initiate and sustain disease burden. In doing so, we hope to uncover cancer-specific vulnerabilities that we can attack with therapeutic interventions. We will use a variety of contemporary techniques to measure differences in metabolism between MB cancer cells and normal developing fetal brain cells. By uncovering these differences, we will develop drugs that target vulnerabilities present exclusively in the cancer cells while sparing normal brain development. We will test these novel preclinical treatment strategies using our established MB mouse model that mimics the different stages of MB disease progression. Metabolic programming as a driver of MB initiation and progression represents an original and actionable discovery that may lead to the development of a new class of treatments with stronger cancer selectivity and fewer neurocognitive side effects.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
473489
Name
Gwynne William
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Reprogrammed pyrimidine metabolism in MYC-amplified medulloblastoma.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Medulloblastoma; Pyrimidine Metabolism; Tumor-Initiating Cells
Abstract
Brain tumors represent the leading cause of childhood cancer mortality, due to their highly aggressive and often incurable nature. Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Whereas the fine-tuning of multimodal therapies have significantly improved the survivorship of MB, there are still fundamental gaps in our molecular understanding of MB recurrence, which remains a terminal diagnosis. Our preliminary findings have shown that MB tumor cells have altered cellular metabolism in comparison to normal developing nervous tissues. The goal of our proposed work is to understand how alterations in cellular metabolism allow recurrent MB tumor cells to initiate and sustain disease burden. In doing so, we hope to uncover cancer-specific vulnerabilities that we can attack with therapeutic interventions. We will use a variety of contemporary techniques to measure differences in metabolism between MB cancer cells and normal developing fetal brain cells. By uncovering these differences, we will develop drugs that target vulnerabilities present exclusively in the cancer cells while sparing normal brain development. We will test these novel preclinical treatment strategies using our established MB mouse model that mimics the different stages of MB disease progression. Metabolic programming as a driver of MB initiation and progression represents an original and actionable discovery that may lead to the development of a new class of treatments with stronger cancer selectivity and fewer neurocognitive side effects.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gwynne, William
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~